Optical spectroscopy to guide photodynamic therapy of head and neck tumors

IEEE Journal on Selected Topics in Quantum Electronics

Volumn 16, Issue 4, 2010, Pages 854-862

  Robinson, Dominic J ^a   Baris Karakullukcu M ^b   Kruijt, Bastiaan ^a   Chad Kanick, Stephen ^a   Van Veen, Robert P L ^a   Amelink, Arjen ^a   Sterenborg, Henricus J C M ^a   Witjes, Max J H ^c   Bing Tan, I ^b,d  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Biomedical applications of optical radiation; blood; cancer; fluorescence spectroscopy; tumors

Indexed keywords

BIOMEDICAL APPLICATIONS; BLOOD CANCER; CANCER; CHLORINS; CLINICAL PRACTICES; DIFFERENTIAL PATH-LENGTH SPECTROSCOPIES; HEAD AND NECK; HEAD-AND-NECK CANCER; HEAD-AND-NECK TUMOR; INTERSTITIAL APPLICATIONS; MEASURED PARAMETERS; OPTICAL GUIDANCE; OPTICAL RADIATIONS; OPTICAL SPECTROSCOPY;

BLOOD; DOSIMETRY; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; MONITORING; PHOTODYNAMIC THERAPY; PLASMONS; RADIOTHERAPY; TUMORS;

OPTICAL PROPERTIES;

EID: 77955512347     PISSN: 1077260X     EISSN: None     Source Type: Journal    
DOI: 10.1109/JSTQE.2009.2035930     Document Type: Article

References (57)

1. B.C.Wilson andM. S. Patterson, "The physics, biophysics and technologyof photodynamic therapy, " Phys.Med. Biol., vol.53, pp. R61-R109, 2008.
2. W. Jerjes, T. Upile, C. S. Betz, M. El Maaytah, S. Abbas, A. Wright et al., "The application of photodynamic therapy in the head and neck, " Dent.Update, vol.34, pp. 478-484, 486, 2007.
3. H. Stepp, T. Beck, T. Pongratz, T. Meinel, F. W. Kreth, J. Ch. Tonn, and W. Stummer, "ALA andmalignant glioma: Fluorescence-guided resectionand photodynamic treatment, " J. Environ. Pathol. Toxicol. Oncol., vol.26, pp. 157-164, 2007.
4. B. W. Henderson, S. M. Waldow, T. S. Mang, W. R. Potter, P. B. Malone, and TJ. Dougherty, "Tumor destruction and kinetics of tumor cell deathin two experimental mouse tumors following photodynamic therapy, "Cancer Res., vol.45, pp. 572-576, 1985.
5. B. Krammer, "Vascular effects of photodynamic therapy, " AnticancerRes., vol.21, pp. 4271-4277, 2001.
6. M. Korbelik and G. J. Dougherty, "Photodynamic therapy-mediated immuneresponse against subcutaneous mouse tumors, " Cancer Res., vol.59, pp. 1941-1946, 1999.
7. Y. G. Qiang, C. M. Yow, and Z. Huang, "Combination of photodynamictherapy and immunomodulation: Current status and future trends, " Med.Res. Rev., vol.28, pp. 632-644, 2008.
8. K. J. Lorenz and H. Maier, "Photodynamic therapy with metatetrahydroxyphenylchlorin(Foscan) in the management of squamous cellcarcinoma of the head and neck: Experience with 35 patients, " Eur. Arch.Otorhinolaryngol., vol.266, pp. 1937-1944, 2009.
9. European Medicines Agencies. H-C-318 Foscan European Public AssessmentRep. 30-34-2009.
10. Visser&KvanNoord, Feiten en Fabels over kanker inNederland, Verenigingvan Nederlandse Kanker Centra. Almelo 2005.
11. Dutch Cancer Registry: De cijfers Van De Nederlandse Kanker registratie:(kankerregistratie.nl).
12. Richtlijn Mondholte en orofarynxcarcinoom. Nederlandse WerkgroepHoofd Hals Tumoren. 2004. Van Zuiden (Alphen a/d Rijn ISBN 90-8523-005-5).
13. C. Hopper, A. Kubler, H. Lewis, I. B. Tan, and G. Putnam, "mTHPCmediatedphotodynamic therapy for early oral squamous cell carcinoma, "Int. J. Cancer, vol.10, pp. 138-146, 2004.
14. S. B. Brown, E. A. Brown, and I. Walker, "The present and future roleof photodynamic therapy in cancer treatment, " Lancet Oncol., vol.5, pp. 497-508, 2004 [Review].
15. H. J. Nyst, R. L. Van Veen, I. B. Tan, R. Peters, S. Spaniol, D. J. Robinson, F. A. Stewart, P. C. Levendag, and H. J. C. M. Sterenborg, "Performanceof a dedicated light delivery and dosimetry device for photodynamic therapyof nasopharyngeal carcinoma: Phantom and volunteer experiments, "Lasers Surg. Med., vol.39, pp. 647-653, 2007.
16. T. Glanzmann, C. Hadjur, M. Zellweger, P. Grosiean, M. Forrer, J. P.Ballini, P. Monnier, H. Van Den Bergh, C. K. Lim, and G. Wagnìeres, "Pharmacokinetics of tetra(m-hydroxyphenyl)chlorin in human plasmaand individualized light dosimetry in photodynamic therapy, " Photochem.Photobiol., vol.67, pp. 596-602, 1998.
17. T. C. Zhu, A. Dimofte, J. C. Finlay, D. Stripp, T. Busch, J. Miles, R. Whittington, S. B. Malkowicz, Z. Tochner, E. Glatstein, and S. M. Hahn, "Optical properties of human prostate at 732 nm measured in mediatedphotodynamic therapy, " Photochem. Photobiol., vol.81, pp. 96-105, 2005.
18. A. Amelink, A. Van Den Heuvel, W. J. deWolf, D. J. Robinson, and H. J.C. M. Sterenborg, "Monitoring PDT by means of superficial reflectancespectroscopy, " J. Photochem. Photobiol. B: Biol., vol.79, pp. 243-251, 2005.
19. J. C. Finlay, T. C. Zhu, A. Dimofte, D. Stripp, S. B. Malkowicz, T. M.Busch, and S. M. Hahn, "Interstitial fluorescence spectroscopy in the humanprostate duringmotexafin lutetium-mediated photodynamic therapy, "Photochem. Photobiol., vol.82, pp. 1270-1278, 2006.
20. R. A. Weersink, A. Bogaards, M. Gertner, S. R. Davidson, K. Zhang, G. Netchev, J. Trachtenberg, and B. C. Wilson, "Techniques for deliveryand monitoring of TOOKAD (WST09)-mediated photodynamic therapyof the prostate: Clinical experience and practicalities, " J. Photochem.Photobiol. B, vol.79, pp. 211-222, 2005. (Pubitemid 40668440)
21. W. J. Cottrell, A. D. Paquette, K. R. Keymel, T. H. Foster, and A. R.Oseroff, "Irradiance-dependent photobleaching and pain in aminolevulinicacid-photodynamic therapy of superficial basal cell carcinomas, " Clin.Cancer Res., vol.14, pp. 4475-4483, 2008.
22. W. M. Star, "Light dosimetry in vivo, " Phys.Med. Biol., vol.42, pp. 763-787, 1997 [A Review].
23. B. C.Wilson, M. S. Patterson, and L. Lilge, "Implicit and explicit dosimetryin photodynamic therapy: A new paradigm, " Lasers Med. Sci., vol.12, pp. 182-199, 1997.
24. D. J. Robinson, H. S. De Bruijn, N. Van Der Veen, M. R. Stringer, S. B.Brown, and W. M. Star, "Fluorescence photobleaching of ALA-inducedprotoporphyrin IX during photodynamic therapy of normal hairlessmouseskin: The effect of light dose and irradiance and the resulting biologicaleffect, " Photochem. Photobiol., vol.67, pp. 140-149, 1998.
25. K.Woodburn, C. K. Chang, S. Lee, B. Henderson, and D. Kessel, "Biodistributionand PDT efficacy of a ketochlorin photosensitizer as a functionof the delivery vehicle, " Photochem. Photobiol., vol.60, pp. 154-159, 1994.
26. B. Aveline, T. Hasan, and R. W. Redmond, "Photophysical and photosensitizingproperties of benzoporphyrin derivative monoacid ring A(BPD-MA), " Photochem. Photobiol., vol.59, pp. 328-335, 1994.
27. T. S. Mang, T. J. Dougherty, W. R. Potter, D. G. Boyle, S. Somer, and J. Moan, "Photobleaching of porphyrins used in photodynamic therapyand implications for therapy, " Photochem. Photobiol., vol.45, pp. 501-506, 1987.
28. K. K. Wang, S. Mitra, and T. H. Foster, "A comprehensive mathematicalmodel of microscopic dose deposition in photodynamic therapy, " Med.Phys., vol.34, pp. 282-293, 2007.
29. B. W. Henderson, T. M. Busch, and J. W. Snyder, "Fluence rate as amodulator of PDT mechanisms, " Lasers Surg. Med., vol.38, pp. 489-493, 2006 [Review].
30. H. W. Wang, M. E. Putt, M. J. Emanuele, D. B. Shin, E. Glatstein, A. G.Yodh, and T.M.Busch, "Treatment-induced changes in tumor oxygenationpredict photodynamic therapy outcome, " Cancer Res., vol.64, pp. 7553-7561, 2004.
31. B.W. Pogue, K.D. Paulsen, J.A.O'Hara, C. M.Wilmot, and H. M. Swartz, "Estimation of oxygen distribution in RIF-1 tumors by diffusion modelbasedinterpretation of pimonidazole hypoxia and eppendorf measurements, "Radiat. Res., vol.155, pp. 15-25, 2001.
32. B. Kruijt, H. S. De Bruijn, A. Van Der Ploeg-Van Den Heuvel, H. J.Sterenborg, and D. J. Robinson, "Laser speckle imaging of dynamicchanges in flow during photodynamic therapy, " Lasers Med. Sci., vol.21, pp. 208-212, 2006.
33. G. Yu, T. Durduran, C. Zhou, T. C. Zhu, J. C. Finlay, T. M. Busch, S. B.Malkowicz, S. M. Hahn, and A. G. Yodh, "Real-time in situ monitoringof human prostate photodynamic therapy with diffuse light, " Photochem.Photobiol., vol.82, pp. 1279-1284, 2006.
34. A. Nijssen, S. Koljenovíc, T. C. B. Schut, P. J. Caspers, and G. J. Puppels, "Towards oncological application of Raman spectroscopy, " J. Biophoton., vol. 2, pp. 29-36, 2009.
35. M. Khurana, E. H. Moriyama, A. Mariampillai, and B. C. Wilson, "Intravitalhigh-resolution optical imaging of individual vessel response tophotodynamic treatment, " J. Biomed. Opt., vol.13, p. 040502.X, 2008.
36. J. M. Mourant, T. M. Johnson, G. Los, and I. J. Bigio, "Noninvasivemeasurement of chemotherapy drug concentrations in tissue: Preliminarydemonstrations of in vivo measurement, " Phys. Med. Biol., vol.44, pp. 1397-1417, 1999.
37. A. Amelink and H. J. C. M. Sterenborg, "Measurement of the local opticalproperties of turbid media using differential pathlength spectroscopy, "Appl. Opt., vol.43, pp. 3048-3054, 2004.
38. A. Amelink, B. Kruijt, D. J. Robinson, and H. J. Sterenborg, "Quantitativefluorescence spectroscopy in turbid media using fluorescence differentialpath length spectroscopy, " J. Biomed. Opt., vol.13, p. 054051, 2008.
39. J. C. Finlay, D. L. Conover, E. L. Hull, and T. H. Foster, "Porphyrinbleaching and PDT-induced spectral changes are irradiance dependent inALA-sensitized normal rat skin in vivo, " Photochem. Photobiol., vol.73, pp. 54-63, 2001.
40. B. Kruijt, H. S. De Bruijn, A. Van Der Ploeg-Van Den Heuvel, R. W. deBruin, H. J. Sterenborg, A. Amelink, and D. J. Robinson, "MonitoringALA- induced PpIX photodynamic therapy in the rat esophagus using fluorescenceand reflectance spectroscopy, " Photochem. Photobiol., vol.84, pp. 1515-1527, 2008.
41. T. Svensson, E. Alerstam, M. Einarsd́ottír, K. Svanberg, and S. Andersson-Engels, "Towards accurate in vivo spectroscopy of the human prostate, "J. Biophoton., vol.1, pp. 200-203, 2008.
42. V. X. Yang, P. J. Muller, P. Herman, and B. C. Wilson, "A multispectralfluorescence imaging system: Design and initial clinical tests in intraoperativePhotofrin-photodynamic therapy of brain tumors, " Lasers Surg.Med., vol.32, pp. 224-232, 2003.
43. H. Stepp, T. Beck, T. Pongratz, T. Meinel, F. W. Kreth, J. Ch. Tonn, and W. Stummer, "ALA andmalignant glioma: Fluorescence-guided resectionand photodynamic treatment, " J. Environ. Pathol. Toxicol. Oncol., vol.26, pp. 157-164, 2007.
44. R. S. Dacosta, B. C. Wilson, and N. E. Marcon, "Spectroscopy and fluorescencein esophageal diseases, " Best Pract. Res. Clin. Gastroenterol., vol. 20, pp. 41-57, 2006.
45. R. L. Van Veen, D. J. Robinson, P. D. Siersema, and H. J. Sterenborg, "Theimportance of in situ dosimetry during photodynamic therapy of Barrett'sesophagus, " Gastrointest. Endosc., vol.64, pp. 786-788, 2006.
46. E. L. Larsen, L. L. Randeberg, O. A. Gederaas, C. J. Arum, A. Hjelde, C. M. Zhao, D. Chen, H. E. Krokan, and L. O. Svaasand, "Monitoringof hexyl 5-aminolevulinate-induced photodynamic therapy in rat bladdercancer by optical spectroscopy, " J. Biomed. Opt., vol.13, p. 044031, 2008.
47. H. Tsutsui, A. J. MacRobert, A. Curnow, A. Rogowska, G. Buonaccorsi, H. Kato, and S. G. Bown, "Optimisation of illumination for photodynamictherapywithmTHPCon normal colon and a transplantable tumour in rats, "Lasers Med. Sci., vol.17, pp. 101-109, 2002.
48. W. J. Cottrell, A. D. Paquette, K. R. Keymel, T. H. Foster, and A. R.Oseroff, "Irradiance-dependent photobleaching and pain in aminolevulinicacid-photodynamic therapy of superficial basal cell carcinomas, " Clin.Cancer Res., vol.14, pp. 4475-4483, 2008.
49. E. Lartigau, A. M. Le Ridant, P. Lambin, P. Weeger, L. Martin, R. Sigal, A. Lusinchi, B. Luboinski, F. Eschwege, and M. Guichard, "Oxygenationof head and neck tumors, " Cancer, vol.71, pp. 2319-2325, 1993.
50. J. C. Finlay, S. Mitra, and T. H. Foster, "In vivo m-THPC photobleachingin normal rat skin exhibits unique irradiance-dependent features, " Photochem.Photobiol., vol.75, pp. 282-288, 2002.
51. C. Hadjur, N. Lange, J. Rebstein, P. Monnier, H. Van Den Bergh, and G.Wagnieres, "Spectroscopic studies of photobleaching and photoproductformation of meta(tetrahydroxyphenyl)chlorin (m-THPC) used in photodynamictherapy. The production of singlet oxygen, " J. Photochem.Photobiol. B, vol.45, pp. 170-178, 1998.
52. S. Coutier, S. Mitra, L. N. Bezdetnaya, R. M. Parache, I. Georgakoudi, T. H. Foster, and F. Guillemin, "Effects of fluence rate on cellsurvival and photobleaching in meta-tetra-(hydroxyphenyl)chlorinphotosensitizedColo 26 multicell tumor spheroids, " Photochem. Photobiol., vol. 73, pp. 297-303, 2001.
53. L.Kunz andA. J.MacRobert, "Intracellular photobleaching of 5, 10, 15, 20-tetrakis(m-hydroxyphenyl) chlorin (Foscan) exhibits a complex dependenceon oxygen level and fluence rate, " Photochem. Photobiol., vol.75, pp. 28-35, 2002.
54. J. S. Dysart, M. S. Patterson, T. J. Farrell, and G. Singh, "Relationshipbetween m-THPC fluorescence photobleaching and cell viability duringin vitro photodynamic treatment of DP16 cells, " Photochem. Photobiol., vol. 75, pp. 289-295, 2002.
55. J. H.Woodhams, L. Kunz, S. G. Bown, and A. J.MacRobert, "Correlationof real-time haemoglobin oxygen saturation monitoring during photodynamictherapy with microvascular effects and tissue necrosis in normal ratliver, " Brit. J. Cancer, vol.91, pp. 788-794, 2004.
56. B. W. Pogue, B. Chen, X. Zhou, and P. J. Hoopes, "Analysis of samplingvolume and tissue heterogeneity on the in vivo detection of fluorescence, "J. Biomed. Opt., vol.10, p. 41206, 2005.
57. U. Sunar, H. Quon, T. Durduran, J. Zhang, J. Du, C. Zhou, G. Yu, R. Choe, A. Kilger, R. Lustig, L. Loevner, S. Nioka, B. Chance, and A. G. Yodh, "Noninvasive diffuse optical measurement of blood flow and blood oxygenationfor monitoring radiation therapy in patients with head and necktumors: A pilot study, " J. Biomed. Opt., vol.11, p. 064021, 2006.